Horizon Pharma Inc has a market cap of $143.5 million; its shares were traded at around $2.42 with and P/S ratio of 20.
This is the annual revenues and earnings per share of HZNP over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of HZNP.
CEO Recent Trades:
- President, Chairman and CEO Timothy P Walbert sold 10,301 shares of HZNP stock on 12/10/2012 at the average price of 2.28. Timothy P Walbert owns at least 99,410 shares after this. The price of the stock has increased by 6.14% since.
CFO Recent Trades:
- EVP & CFO Vaere Robert J De sold 20,544 shares of HZNP stock on 01/02/2013 at the average price of 2.36. Vaere Robert J De owns at least 51,092 shares after this. The price of the stock has increased by 2.54% since.
This is the insider trade history vs. stock price of HZNP. For the complete insider trading history of HZNP, click here.
Directors and Officers Recent Trades:
- Director Jeffrey W Bird bought 575,356 shares of HZNP stock on 09/25/2012 at the average price of 3.49. Jeffrey W Bird owns at least 2,208,470 shares after this. The price of the stock has decreased by 30.66% since.
- EVP & Chief Commercial Officer Todd N Smith sold 6,998 shares of HZNP stock on 01/02/2013 at the average price of 2.36. Todd N Smith owns at least 22,570 shares after this. The price of the stock has increased by 2.54% since.
- SVP, Managed Care & Comm. Dev. Michael Adatto sold 6,998 shares of HZNP stock on 01/02/2013 at the average price of 2.36. Michael Adatto owns at least 22,911 shares after this. The price of the stock has increased by 2.54% since.
For the complete insider trading history of HZNP, click here.







RSS